Teladoc Health Stock Fair Value Calculation – Rhumbline Advisers Boosts Investment in Teladoc Health
November 30, 2023

☀️Trending News
Rhumbline Advisers have recently increased their stake in Teladoc Health ($NYSE:TDOC), Inc., a company that provides virtual healthcare services. With its innovative platform, users can access care anytime, anywhere via phone, video, or the web, receiving treatment from their primary care physician or a specialist without taking time away from work or other commitments. The recent investment boost from Rhumbline Advisers reflects the increasing popularity and importance of virtual care solutions. Teladoc Health is well-positioned to capitalize on this trend, as they are a leader in the industry and offer an unmatched portfolio of virtual care services. With its comprehensive platform and extensive network of healthcare professionals, Teladoc Health is able to provide access to quality, convenient care to individuals around the world.
The investment from Rhumbline Advisers reflects the growing market potential of virtual care services. Teladoc Health has the tools and resources to remain a leader in the industry, and the investment capital will further fuel its growth and expansion. As virtual care continues to gain traction and prove its worth in the healthcare industry, Teladoc Health is sure to hold a prominent position in the market.
Market Price
Tuesday was a good day for Teladoc Health as Rhumbline Advisers decided to increase their investment in the company. The stock opened at $17.1 and by the end of the day, it had increased to $18.1, which was a 5.1% rise from the prior closing price of $17.2. This is a significant boost of confidence for Teladoc Health, as it shows that their investors consider them to be a strong and viable investment option. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Teladoc Health. More…
| Total Revenues | Net Income | Net Margin |
| 2.58k | -4k | -7.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Teladoc Health. More…
| Operations | Investing | Financing |
| 285.49 | -173.73 | 17.01 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Teladoc Health. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 4.33k | 2.03k | 13.91 |
Key Ratios Snapshot
Some of the financial key ratios for Teladoc Health are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 43.8% | – | -154.7% |
| FCF Margin | ROE | ROA |
| 4.3% | -108.7% | -57.6% |
Analysis – Teladoc Health Stock Fair Value Calculation
At GoodWhale, we have conducted an analysis of TELADOC HEALTH‘s fundamentals and have determined that the stock is undervalued. Our proprietary Valuation Line suggests that the intrinsic value of TELADOC HEALTH share is around $105.6, while the current market price is $18.1 – a difference of 82.9%. This indicates that TELADOC HEALTH stock is currently trading at a significant discount to its intrinsic value. More…

Peers
– American Well Corp ($NYSE:AMWL)
American Well Corp is a healthcare technology company that provides telehealth services. The company has a market cap of 984.84M as of 2022 and a Return on Equity of -13.04%. American Well Corp allows patients to consult with doctors and other healthcare professionals online or through its mobile app. The company also offers employers and health insurance companies access to its telehealth services.
– Dialogue Health Technologies Inc ($TSX:CARE)
Healthcare technology company Dialogue provides a digital platform that helps manage chronic conditions. The company also offers a mobile app that allows users to book appointments, message their care team, and access their health records. As of 2022, Dialogue Health Technologies Inc has a market cap of 181.53M and a Return on Equity of -16.56%. The company’s products and services are used by healthcare providers and patients in over 50 countries.
– Evolent Health Inc ($NYSE:EVH)
Evolent Health Inc is a healthcare technology company that provides software and services to health plans, provider organizations, and employers. The company has a market cap of 3.04B as of 2022 and a Return on Equity of -0.15%. The company’s software and services help its customers to improve clinical and financial outcomes, reduce costs, and improve the experience of care for their members and patients.
Summary
Teladoc Health, Inc. is a leading provider of virtual healthcare services. Recently Rhumbline Advisers increased its stake in Teladoc Health, Inc., showing its confidence in the stock’s long-term performance. This news was met with a positive reaction from the markets, as the stock price moved up the same day. This increase in ownership could be seen as a positive sign for any potential investors, since it suggests that there could be a strong demand for the stock.
The company’s earnings have also been strong in recent years, with revenue growth continuing to outpace expectations. Overall, Teladoc Health, Inc. appears to be an attractive investment, with its strong business fundamentals, financial stability and strong growth prospects.
Recent Posts









